Erratum: Mephedrone and methylenedioxypyrovalerone (MDPV), major constituents of “bath salts,” produce opposite effects at the human dopamine transporter (Psychopharmacology, (2013), 227, (493-499), 10.1007/s00213-013-2967-2);Mephedrone and methylenedioxypyrovalerone (MDPV), major constituents of "bath salts," produce opposite effects at the human dopamine transporter

Psychopharmacology

Volumn 227, Issue 3, 2013, Pages 493-499

  Cameron, Krasnodara ^a   Kolanos, Renata ^a   Verkariya, Rakesh ^a   De Felice, Louis ^a   Glennon, Richard A ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

Cocaine; Dopamine transporter; Drug abuse; hDAT; Mephedrone; Methamphetamine; Methcathinone; Methylenedioxypyrovalerone; Synthetic cathinones

Indexed keywords

4' METHYLMETHCATHINONE; CATHINONE; COCAINE; DOPAMINE TRANSPORTER; HALOPERIDOL; METHAMPHETAMINE; METHCATHINONE; METHYLENEDIOXYPYROVALERONE; PYROVALERONE; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; DRUG POTENCY; DRUG STRUCTURE; ELECTROPHYSIOLOGY; FEMALE; NONHUMAN; OOCYTE; PRIORITY JOURNAL; XENOPUS;

EID: 84878115326     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-013-3056-2     Document Type: Erratum

References (32)

1. Balint EE, Falkay G, Balint GA (2009) Khat - a controversial plant. Wein Klin Wochenschr 121:604-614
2. Baumann MH, Ayestas MA Jr, Partilla JS, Sink JR, Shulgin AT, Daley PF, Brandt SD, Rothman RB, Ruoho AE, Cozzi NV (2012) The designer methcathinone analogs, mephedrone and methylone, are substrates for monoamine transporters in brain tissue. Neuropsychopharmacology 37:1192-1203
3. Dal Cason TA, Young R, Glennon RA (1997) Cathinone: an investigation of several N-alkyl and methylenedioxy analogs. Pharmacol Biochem Behav 58:1109-1116
4. de Durnaga S, Sanchez J (1929) A homolog of ephedrine. Bull Soc Chim Fr 45:284-286
5. DeFelice LJ, Goswami T (2007) Transporters as channels. Annu Rev Physiol 69:87-112
6. Federal Register (2011) Schedules of controlled substances: temporary placement of three synthetic cathinones into Schedule I. Fed Regist 76:65371-65375, October 21
7. Fuwa T, Fukumori N, Tanaka T, Kubo Y, Ogata A, Uehara S, Honda Y, Kodama T (2007) Microdialysis study of drug effects on central nervous system: changes of dopamine levels in mice striatum after oral administration of methylenedioxypyrovalerone. Ann Rep Tokyo Metr Inst P H 58:287-292
8. Glennon RA, Showalter D (1981) The effect of cathinone and several related derivatives on locomotor activity. Res Commun Subst Abuse 2:186-192
9. Glennon RA, Young R (2011) Drug discrimination: application to medicinal chemistry and drug studies. Wiley, Hoboken
10. Glennon RA, Young R, Martin BR, Dal Cason TA (1995) Methcathinone ("CAT"): an enantiomeric potency comparison. Pharmacol Biochem Behav 50:601-606
11. Glennon RA, Yousif M, Naiman NA, Kalix P (1987) Methcathinone: a new and potent amphetamine-like agent. Pharmacol Biochem Behav 26:547-551
12. Hadlock GC, Webb KM, McFadden LM, Chu PW, Ellis JD, Allen SC, Andrenyak DM, Vieira-Brock PL, German CL, Conrad KM, Hoonakker AJ, Gibb JW, Wilkins DG, Hanson GR, Fleckenstein AE (2011) 4-Methylmethcathinone (mephedrone): neuropharmacological effects of a designer stimulant of abuse. J Pharmacol Exp Ther 339:530-536
13. Iversen LE (2010) Consideration of the cathinones. Advisory Council on the Misuse of Drugs. A report submitted to the Home Secretary of the UK (March 31, 2010)
14. -, and pH dependence of the human choline transporter (hCHT) in Xenopus oocytes: the proton inactivation hypothesis of hCHT in synaptic vesicles. J Neurosci 26:9851-9859
15. Kalix P (1980) A constituent of khat leaves with amphetamine-like releasing properties. Eur J Pharmacol 68:213-215
16. Kalix P (1984) The pharmacology of khat. Gen Pharmacol 15:179-187
17. Kalix P (1996) Catha edulis, a plant that has amphetamine effects. Pharm World Sci 18:69-73
18. Kalix P (1992) Cathinone, a natural amphetamine. Pharmacol Toxicol 70:77-86
19. Kalix P, Braeden O (1985) Pharmacological aspects of the chewing of khat leaves. Pharmacol Rev 37:149-164
20. Kalix P, Glennon RA (1986) Further evidence for an amphetamine-like mechanism of action of the alkaloid cathinone. Biochem Pharmacol 35:3015-3019
21. Kehr J, Ichinose F, Yoshitake S, Goiny M, Sievertsson T, Nyberg F, Yoshitake T (2011) Mephedrone, compared to MDMA (ecstasy) and amphetamine, rapidly increases both dopamine and serotonin levels in nucleus accumbens of awake rats. Br J Pharmacol 164:1949-1958
22. Kennedy JG, Teague J, Fairbanks L (1980) Qat use in North Yemen and the problem of addiction: A study in medical anthroplology. Cult Med Psychiat 4:311-344
23. Köppe H, Ludwig G, Holstein W, Zile L (1969) 1-(3,4-Methylenedioxy- phenyl-2-pyrrlidino-alkanones-(1). US Patent 3,478,050, November 11, 1969.
24. Martínez-Clemente J, Escubedo E, Pubill D, Camarasa J (2012) Interaction of mephedrone with dopamine and serotonin targets in rats. Eur Neuropsychopharmacol 22:231-236
25. Meltzer PC, Butler D, Deschamps JR, Madras BK (2006) 1-(4-Methylphenyl)- 2-pyrrolidin-1-yl-pentan-1-one (pyrovalerone) analogues: a promising class of monoamine uptake inhibitors. J Med Chem 49:1420-1432
26. Ramsey S, De Felice LJ (2002) Serotonin transporter function and pharmacology are sensitive to expression level: evidence for an endogenous regulatory factor. J Biol Chem 277:14475-14482
27. Rodriguez-Menchaca AA, Solis E Jr, Cameron K, De Felice LJ (2012) (+)Amphetamine induces a persistent leak in the human dopamine transporter: Molecular stent hypothesis. Br J Pharmacol 156:2749-2757
28. Simmler LD, Buser TA, Donzelli M, Schramm Y, Diue LH, Huwyler J, Chaboz S, Hoener MC, Liechti ME (2012) Pharmacological characterization of designer cathinones in vitro. Br J Pharmacol. doi: 10.1111/j.1476-5381.2012.02145.x
29. Sonders MS, Zhu SJ, Zahniser NR, Kavanaugh MP, Amara SG (1997) Multiple ionic conductances of the human dopamine transporter: the actions of dopamine and psychostimulants. J Neurosci 17:960-174
30. Spiller HA, Ryan ML, Weston RG, Jansen J (2011) Clinical experience with and analytical confirmation of 'bath salts' and 'legal highs' (synthetic cathinones) in the United States. Clin Toxicol 49:499-505
31. United Nations (1979) The botany and chemistry of khat. United Nations Narcotics Laboratory Report of an Expert Group, Antananarivo, Madagascar, November 27-December 1, 1978, MNAR Document 3/1979
32. Young R, Glennon RA (1998) Discriminative stimulus effects of S(-)-methcathinone (MCAT): a potent stimulant drug of abuse. Psychopharmacol (Berl) 140:250-256